Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

AbortionFetal Development Issues in Law and Medicine

Psychological Impact of Abortion due to Fetal Anomaly: A Review of Published Research

Additional Author: Eoghan de Faoite, M.D

Abstract

Over the past several decades, prenatal testing for fetal anomalies has become standard across the developed world. Most women who learn of a severe anomaly during pregnancy elect to terminate. The authors reviewed ten studies which examined the psychological sequelae of pregnant women following prenatal diagnoses of severe life limiting conditions. Based on the available data, the authors found evidence that women who abort due to a poor prenatal diagnosis are at higher risk of post-traumatic stress and depression than women who continue with pregnancy. They also found that current practice is to make reactive recommendations for post-abortion care, suggesting a presumption in favor of abortion, leaving alternatives like perinatal hospice inadequately explored. This review critiques that approach, recommending that doctors and patients need to have the best possible information before a decision is made.

Read Complete Article

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

A graphic showing an outline of Kentucky with the text KENTUCKY ABORTION STATISTICS centered over it, detailing 2022 abortion data.

Abortion Reporting: Kentucky (2025)

An outline of the state of Alabama with the text ALABAMA ABORTION STATISTICS centered over it, reflecting current abortion reporting.

Abortion Reporting: Alabama (2025)

Text reading Virginia Abortion Statistics, providing 2022 abortion data, centered over a light gray silhouette of the state of Virginia inside a white circle on a blue background.

Abortion Reporting: Virginia (2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image